Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
IGM Biosciences, Inc.
Immodulon Therapeutics Ltd
Eli Lilly and Company
Eli Lilly and Company
Valerio Therapeutics